Currently we are streamlining the processes for personalized immunotherapies which include Cancer Vaccines at our cGMP grade production facility.
Data evaluation
We will evaluate the impact of our platform on the clinical outcomes and quality of life of cancer patients using various methods.
Such as randomized controlled trials, observational studies, patient-reported outcomes measures (PROMs), health-related quality of life (HRQoL) measures, etc.
Usability and User Satisfaction
We will also evaluate the usability and user satisfaction of our platform using various methods, such as user feedback surveys, usability testing, user interface design, etc.